Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection.
Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species.
A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic.
Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections.
Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1.
A protein synthesis routes.
Rethinking Optimal Immunogens to Face SARS-CoV-2 Evolution Through Vaccination.
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial.
Production and characterization of novel Anti-HIV Fc-fusion proteins in plant-based systems: Nicotiana benthamiana & tobacco BY-2 cell suspension.